Looks like you clickedhttps://news.abbvie.com/news/abbvie-announces-us-fda-approval-venclexta-venetoclax-tablets-in-combination-with-rituximab-as-fixed-duration-treatment-for-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-patients-who-have-received-one-prior-therapy.htm
If you do not want to visit that page, you can close this browser tab.
